A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Verastem, Inc.
Verastem, Inc.
ALX Oncology Inc.
BicycleTx Limited
NiKang Therapeutics, Inc.
Pfizer
Eli Lilly and Company
Daiichi Sankyo
Eli Lilly and Company
Pliant Therapeutics, Inc.
Eli Lilly and Company
Eli Lilly and Company
AstraZeneca
Merck Sharp & Dohme LLC
Pfizer
Pfizer
Amgen
Exelixis
TuHURA Biosciences, Inc.
Eli Lilly and Company
Eli Lilly and Company
Eli Lilly and Company
AstraZeneca
Eli Lilly and Company
Eli Lilly and Company
Avenzo Therapeutics, Inc.
Kivu Bioscience Inc.
BioNTech SE
BeOne Medicines
MOMA Therapeutics
Astellas Pharma Inc
Astellas Pharma Inc
Hoffmann-La Roche
7 Hills Pharma, LLC
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
ALX Oncology Inc.
AstraZeneca
Plexium, Inc.
Crescent Biopharma, Inc.
Beijing Biotech
Parabilis Medicines, Inc.
AVEO Pharmaceuticals, Inc.
Pfizer
Eikon Therapeutics
BriaCell Therapeutics Corporation
Coherus Oncology, Inc.
Suzhou Abogen Biosciences Co., Ltd.
Beijing Biotech
ModernaTX, Inc.
Alterome Therapeutics, Inc.
IDEAYA Biosciences